Drugs / polyethylene glycol
polyethylene glycol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00390598 Comparator | Sep 2005 → Dec 2006 | — | Umeå University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polyethylene glycol | “Four liters or more of orally taken polyethylene glycol solution (PEG) has proved to be an effective large-bowel cleansing method prior to colonoscopy.” PMID 20812020 ↗ Sep 2010 |
| Known as | Laxabon (R) =PEG solution | “Laxabon (R) =PEG solution” NCT00390598 ↗ |
| Known as | PEG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00390598 ↗ |
| Route | Oral | “Four liters or more of orally taken polyethylene glycol solution” PMID 20812020 ↗ Sep 2010 |